Comparative receptor binding analyses of cannabinoid agonists and antagonists

Journal of Pharmacology and Experimental Therapeutics

Volumn 285, Issue 1, 1998, Pages 285-292

  Thomas, Brian F ^a   Gilliam, Anne F ^a   Burch, David F ^a   Roche, Michael J ^a   Seltzman, Herbert H ^a  

^a RTI INTERNATIONAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; AMIDE; ANANDAMIDE; CANNABIDIOL; CANNABINOID; CANNABINOID RECEPTOR; CANNABINOL; DRONABINOL; RIMONABANT;

ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BINDING COMPETITION; BINDING KINETICS; BRAIN; DRUG RECEPTOR BINDING; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STRUCTURE ACTIVITY RELATION;

ANALGESICS; ANIMALS; BINDING, COMPETITIVE; CANNABINOIDS; CYCLOHEXANOLS; MALE; MODELS, MOLECULAR; PIPERIDINES; PYRAZOLES; RATS; RATS, INBRED F344;

EID: 0031981037     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Aceto MD, Scates SM, Lowe JA and Martin BR (1995) Cannabinoid precipitated withdrawal by the selective cannabinoid receptor antagonist, SR 141716A. Ear J Pharmacol 282:1-3.
2. Adams IB, Ryan W, Singer M, Thomas BF, Compton DR, Razdan RK and Martin BR (1995) Evaluation of cannabinoid receptor binding and in vivo activities for anandamide analogs. J Pharmacol Exp Ther 273:1172-1181.
3. Beardsley PM, Scimeca JA and Martin BR (1987) Studies on the agonistic activity of delta 9-11-tetrahydrocannabinol in mice, dogs and rhesus monkeys and its interactions with delta 9-tetrahydrocannabinol. J Pharmacol Exp Ther 241:521-526.
4. Bramblett RD, Panu AM. Ballesteros JA and Reggio PH (1995) Construction of a 3D model of the cannabinoid CB1 receptor: determination of helix ends and helix orientation. Life Sci 56:1971-1982.
5. Casiano FM, Arnold R, Haycock D, Kuster J and Ward SJ (1991) Putative amino-alkylindoles (AAI) antagonists, in Problems of Drug Dependence 1990: Proceedings of the 52nd Annual Meeting of the Committee on Problems of Drug Dependence (Harris LS, ed) NIDA Research Monograph no. 105, p 105, DHHS Publication (ADM) 91-1753, Rockville, MD.
6. Compton DR, Rice KC, De Costa BR, Razdan RK, Melvin LS, Johnson MR and Martin BR (1993) Cannabinoid structure-activity relationships: Correlation of receptor binding and in vivo activities. J Pharmacol Exp Ther 265:218-226.
7. Devane WA, Dysarz II FA, Johnson MR, Melvin LS and Howlett AC (1988) Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol 34:605-613.
8. Felder CC, Joyce KE, Briley EM, Mansouri J, Mackie K, Blond O, Lai Y, Ma AL and Mitchell RL (1995) Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors. Mol Pharmacol 48:443-450.
9. Gasteiger J and Marsili M (1978) A new model for calculating atomic charges in molecules. Tetrahedron Lett 34:3181-3184.
10. Herkenham M, Lynn AB, Little MD, Johnson MR, Melvin LS, de Costa BR and Rice KC (1990) Cannabinoid receptor localization in brain. Proc Natl Acad Sci USA 87:1932-1936.
11. Houston, D. B., Lan, R., Pigg, J. J., Wilken, G., Howlett, A. C. and Makriyannis, A. (1997) Structure-activity relationship of pyrazole compounds to CB1 receptor affinity and function, in International Cannabinoid Research Society: 1997 Symposium on the Cannabinoids, p. 28, International Cannabinoid Research Society (ISBN: 09658053-0-1), 1997.
12. Howlett AC, Johnson MR, Melvin LS and Milne GM (1988) Nonclassical cannabinoid analgetics inhibit adenylate cyclase: development of a cannabinoid receptor model. Mol Pharmacol 33:297-302.
13. Kearn CS and Hilliard CJ (1997) Rat microglial cells express the peripheral-type cannabinoid receptor (CB2) which is negatively coupled to adenyl cyclase, in International Cannabinoid Research Society: 1997 Symposium on the Cannabinoids, p.61, International Cannabinoid Research Society (ISBN: 09658053-0-1), 1997.
14. Matsuda LA, Lolait SJ, Brownstein M, Young A and Bonner TI (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346:561-564.
15. Melvin LS, Milne GM, Johnson MR, Subramaniam B, Wilken GH and Howlett AC (1993) Structure-activity relationships for cannabinoid receptor-binding and analgesic activity: Studies of bicyclic cannabinoid analogs. Mol Pharmacol 44:1008-1015.
16. Munro S, Thomas KL and Abu-Shaar M (1993) Molecular characterization of a peripheral receptor for cannabinoids. Nature 365:61-65.
17. Pertwee R, Griffin G, Fernando S, Li X, Hill A and Makriyannis A (1995) AM630 a competitive cannabinoid receptor antagonist. Life Sci 56:23-24.
18. 3H]SR141716A. Neuroreporth 7:789-792.
19. Razdan RK (1986) Structure-activity relationships in the cannabinoids. Pharm Rev 38:75-149.
20. Reggio PH (1987) Molecular determinants of cannabinoid activity: refinement of a molecular reactivity template. Natl Inst Drug Abuse Res Monogr 79:82-95.
21. Reggio PH (1993) Molecular determinants of cannabinoid activity: toward the disign of cannabinoid analgesics with reduced psychoactive liability. Natl Inst Drug Abuse Res Monogr 134:210-228.
22. 3H]SR141716A, a selective brain (CB1) cannabinoid receptor antagonist. Presentation at the International Cannabis Research Society, Scottsdale, AZ.
23. Rinaldi-Carmona M, Barth F, Heaulme M, Shire D, Calandra B, Congy C, Martinez S, Maruani J, Neliat G and Caput D (1994) SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett 350:240-244.
24. Seltzman HH, Carroll FI, Burgess JP, Wyrick CD and Burch DF (1995) Synthesis, spectral studies and tritiation of the cannabinoid antagonist SR141716A. J Chem Soc Chem Commun 1549.
25. Shire D, Carillon C, Kaghad M, Calandra B, Rinaldi-Carmona M, Le Fur G, Caput D and Ferrara P (1995) An amino-terminal variant of the central cannabinoid receptor resulting from alternative splicing. J Biol Chem 270:3726-3731.
26. Shire D, Calandra B, Delpech M, Dumont X, Kaghad M, Le Fur G, Caput D and Ferrara P (1996) Structural features of the central cannabinoid CB1 receptor involved in the binding of the specific CB1 antagonist SR141716A. J Biol Chem 271:6941-6946.
27. Showalter VM, Compton DR, Martin BR and Abood ME (1996) Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): Identification of cannabinoid receptor subtype selective ligands. J Pharmacol Exp Ther 278:989-999.
28. Skaper SD, Buriani A, Dal Toso R, Petrelli L, Rimanello S, Facci L and Leon A (1996) The ALIAmide palmitoylethanolamide and cannabinoids, but not anandamide, are protective in a delayed postglutamate paradigm of excitotoxic death in cerebellar granule neurons. Proc Natl Acad Sci USA 93:3984-3989.
29. Thomas BF, Compton DR, Martin BR and Semus SF (1991) Modeling the cannabinoid receptor: a three dimensional quantitative structure-activity analysis. Mol Pharmacol 40:656-665.
30. 9-THC-DMH. J Pharmacol Exp Ther 263:1383-1390.
31. Thomas BF, Adams IB, Mascarella SW, Martin BR and Razdan RK(1996) Structure-activity analysis of anandamide analogs: relationship to a cannabinoid pharmacophore. J Med Chem 39:471-479.
32. Ward SJ, Baizman E, Bell M, Childers S, D'Ambra T, Eissenstat M, Estep K, Haycock D, Howlett A, Luttinger D, Miller M and Pacheco M (1991) Aminoalkylindoles (AAIs): A new route to the cannabinoid receptor? in Problems of Drug Dependence 1990: Proceedings of the 52nd Annual Meeting of the Committee on Problems of Drug Dependence (Harris LS, ed) NIDA Research Monograph no. 105, pp 304-305, DHHS Publication (ADM)91-1753, Rockville, MD.